P-glycoprotein-mediated multidrug resistance phenotype of L1210/VCR cells is associated with decreases of oligo- and/or polysaccharide contents

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1639, Issue 3, 2003, Pages 213-224

  Fiala, R ^a   Sulova Z ^a   El Saggan, A H ^a   Uhrik B ^a   Liptaj, T ^b   Dovinova I ^c   Hanusovska E ^d   Drobna Z ^e   Barancik M ^e   Breier, A ^a  

^a INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

^b SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^c INSTITUTE OF VIROLOGY   (Slovakia)

^d INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

^e INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Concanavalin A; L1210 cell line; Multidrug resistance; Oligo (poly )saccharides; P glycoprotein; Ruthenium red

Indexed keywords

ADENOSINE TRIPHOSPHATE; CONCANAVALIN A; GLYCOPROTEIN; GLYCOPROTEIN P; OLIGOSACCHARIDE; POLYSACCHARIDE; RUTHENIUM RED; SEPHAROSE; URIDINE DIPHOSPHATE SUGAR; VINCRISTINE;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL LINE; CELL STRAIN; CELL SURFACE; CONTROLLED STUDY; GENETIC RESISTANCE; HISTOCHEMISTRY; LEUKEMIA CELL; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN INTERACTION; SPECTRUM; STAINING;

MURINAE;

EID: 10744228597     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2003.09.009     Document Type: Article

References (55)

1. Kvačkajová-Kišucká J., Barančí k M., Breier A. Drug transporters and their role in multidrug resistance of neoplastic cells. Gen. Physiol. Biophys. 20:2001;215-237.
2. Bosch I., Croop J. P-glycoprotein multidrug resistance and cancer. Biochim. Biophys. Acta. 1288:1996;F37-F54.
3. Roninson I.B., Chin J.E., Choi K., Gros P., Houseman D.E., Fojo A., Shen D.W., Gottesman M.M., Pastan I. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 83:1986;4538-4542.
4. Gottesman M.M., Hrycyna C.A., Schoenlein P.V., Germann U.A., Pastan I. Genetic analysis of the multidrug transporter. Annu. Rev. Genet. 29:1995;607-649.
5. Simon S.M., Schindler M. Cell biological mechanisms of multidrug resistance in tumours. Proc. Natl. Acad. Sci. U. S. A. 91:1994;3497-3504.
6. Ambudkar A.S.V., Dey S., Hrycyna C.A., Ramachandra M., Pastan I., Gottesman M. Biochemical, cellular and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39:1999;361-398.
7. Chou Y.Y., Cheng A.L., Hsu H.C. Expression of P-glycoprotein and p53 in advanced hepatocellular carcinoma treated by single agent chemotherapy: clinical correlation. J. Gastroenterol. Hepatol. 12:1997;569-575.
8. Endicott J.A., Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58:1989;137-171.
9. Broxterman H.J., Pinedo H.M., Kuiper C.M., Schuurhuis G.J., Lankelma J. Glycolysis in P-glycoprotein-overexpressing human tumor cell lines. Effects of resistance-modifying agents. FEBS Lett. 247:1989;405-410.
10. 31P nuclear magnetic resonance characterization and 2-deoxyglucose toxicity. Cancer Res. 51:1991;1638-1644.
11. Lyon R.C., Cohen J.S., Faustino P.J., Megnin F., Myers C.E. Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy. Cancer Res. 48:1988;870-877.
12. Fanciulli M., Bruno T., Castiglione S., Del Carlo C., Paggi M.G., Floridi A. Glucose metabolism in adriamycin-sensitive and-resistant LoVo human colon carcinoma cells. Oncol. Res. 5:1993;357-362.
13. Gessner T., Vaughan L.A., Beehler B.C., Bartels C.J., Baker R.M. Elevated pentose cycle and glucuronyl transferase in daunorubicin-resistant P388 cells. Cancer Res. 50:1990;3921-3927.
14. Poleková L., Barančík M., Mrázová T., Pirker R., Wallner J., Sulová Z., Breier A. Adaptation of mouse leukemia cells L1210 to vincristine. Evidence for expression of P-glycoprotein. Neoplasma. 39:1992;73-77.
15. Boháčová V., Kvačkajová J., Barančík M., Drobná Z., Breier A. Glutathione S-transferase does not play a role in multidrug resistance of L1210/VCR cell line. Physiol. Res. 49:2000;447-453.
16. Breier A., Drobná Z., Dočolomanský P., Barančík M. Cytotoxic activity of several unrelated drugs on L1210 mouse leukemic cell sublines with P-glycoprotein (PGP) mediated multidrug resistance (MDR) phenotype. A QSAR study. Neoplasma. 47:2000;100-106.
17. Breier A., Drobná Z., Boháčova V., Brančik M. Resistance of L1210 mouse leukemic cell line characterise by overexpression of ATP dependent drug transporter to several drugs. Chem. Papers. 52:1998;418. (focus issue).
18. 2+-entry blockers, neuroleptics and local anaesthetics on P-glycoprotein-mediated vincristine resistance of L1210/VCR cell line. Drugs Exp. Clin. Res. 20:1994;13-18.
19. Barančík M., Boháčová V., Kvačkajová J., Hudecová S., Križanová O., Breier A. SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance. Eur. J. Pharm. Sci. 14:2001;29-36.
20. Kišucká J., Barančík M., Boháč ová V., Breier A. Reversal effect of specific inhibitors of extracellular-signal regulated protein kinase pathway on P-glycoprotein mediated vincristine resistance of L1210 cells. Gen. Physiol. Biophys. 20:2001;439-444.
21. Breier A., Drobná Z., Barančík M. Direct interaction between verapamil and doxorubicin caused the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210 cells. Neoplasma. 45:1998;248-253.
22. Uhrík B., Tribulová N., Klobušická M., Barančík M., Breier A. Characterisation of morphological and histochemical changes induced by overexpression of P-glycoprotein in mouse leukemic cell line L1210. Neoplasma. 41:1994;83-88.
23. Walther W., Stein U. Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs. J. Cancer. Res. Clin. Oncol. 120:1994;471-478.
24. Stein U., Walther W., Shoemaker R.H. Modulation of mdr1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance. Br. J. Cancer. 74:1996;1384-1391.
25. Noonan K.E., Beck C., Holzmayer T.A., Chin J.E., Wunder J.S., Andrulis I.L., Gazdar A.F., Willman C.L., Griffith B., Vonhoff D.D., Roninson I.B. Quantitative-analysis of MDR1 (multidrug resistance) gene-expression in human tumors by polymerase chain-reaction. Proc. Natl. Acad. Sci. U. S. A. 87:1990;7160-7164.
26. Wu L., Smythe A.M., Stinson S.F., Mullendore L.A., Monks A., Scudiero D.A., Paull K.D., Koutsoukos A.D., Rubinstein L.V., Boyd M.R., Shoemaker R.H. Multidrug-resistant phenotype of disease-oriented panels of human tumor-cell lines used for anticancer drug screening. Cancer Res. 52:1992;3029-3034.
27. Hamada H., Tsuruo T. Purification of the P-glycoprotein associated with multidrug resistance: P-glycoprotein is an ATPase. J. Biol. Chem. 263:1988;1454-1458.
28. Fairbanks G., Steck T.L., Wallach D.F.H. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry. 10:1971;2606-2617.
29. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76:1979;4450-4454.
30. Hanušovská E., Dovinová I., Tkáč I., Novotný L. Application of NMR spectroscopy in biochemical studies of tumor cells sensitive and resistant to anticancer drugs. Neoplasma. 45:1998;187-197.
31. Farkaš V., Sulova Z., Lehotsky J. Effect of light on the concentration of adenine-nucleotides in Trichoderma viride. J. Gen. Microbiol. 131:1985;317-320.
32. Tang G.Q., Sturm A. Antisense repression of sucrose synthase in carrot (Daucus carota L.) affects growth rather than sucrose partitioning. Plant. Mol. Biol. 41:1999;465-479.
33. El-Saggan A.H., Uhrík B. Improved staining of negative binding sites with ruthenium red on cryosections of frozen cells. Gen. Physiol. Biophys. 21:2002;457-461.
34. Mislovičová D., Chudinová M., Gemeiner P., Dočolomanský P. Affinity chromatography of invertase on Concanavalin A-bead cellulose matrix: the case of an extraordinary strong binding glycoenzyme. J. Chromatogr. B. 644:1995;145-153.
35. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685. (London).
36. Luft J.H. Ruthenium red and violet: I. Chemistry, purification, methods of use for electron microscopy and mechanism of action. Anat. Rec. 171:1971;347-368.
37. Luft J.H. Ruthenium red and violet: II. Fine structural localization in animal tissues. Anat. Rec. 171:1971;369-416.
38. Lavie Y., Fiucci G., Liscovitch M. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J. Biol. Chem. 273:1998;32380-32383.
39. Jia L., Allen P.D., Macey M.G., Grahn M.F., Newland A.C., Kelsey S.M. Mitochondrial electron transport chain activity, but not ATP synthesis, is required for drug-induced apoptosis in human leukaemic cells: a possible novel mechanism of regulating drug resistance. Br. J. Haematol. 98:1997;686-698.
40. Jia L., Liu K.Z., Newland A.C., Mantsch H.H., Kelsey S.M. Pgp-positive leukaemic cells have increased mtDNA but no increased rate of proliferation. Br. J. Haematol. 107:1999;861-869.
41. Doige C.A., Sharom F.J. Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells. Biochim. Biophys. Acta. 1109:1992;161-171.
42. Hamada H., Tsuruo T. Characterisation of the ATPase activity of the Mr 170. 000 to 180 000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells Cancer Res. 48:1988;4926-4932.
43. Pinard P.V., Kepler J.A., Pettit G.R., Hamel E. Sustained intracellular retention of dolastatin 10 causes its potent antimitotic activity. Mol. Pharmacol. 57:2000;180-187.
44. Ujházy P., Berleth E.S., Pietkiewicz J.M., Kitano H., Skaar J.R., Ehrke M.J., Mihich E. Evidence for the involvement of ecto-5′- nucleotidase (CD73) in drug resistance. Int. J. Cancer. 68:1996;493-500.
45. Achyuthan K.E., Achyuthan A.M. Comparative enzymology, biochemistry and pathophysiology of human exo-a-sialidases (neuraminidases). Comp. Biochem. Physiol., B. 129:2001;29-64.
46. Yogeeswaran G., Salk P.L. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science. 212:1981;1514-1516.
47. Prasad S.B., Sodhi A. Effect of cis-dichlorodiammine platinum (II) on the agglutinability of tumour and normal cells with concanavalin A and wheat germ agglutinin. Chem. Biol. Interact. 36:1981;355-367.
48. Prasad S.B., Sodhi A. Effect of cis-Dichlorodiammine platinum (II) on surface of tumor and normal cells: biochemical, fluorescence and electron microscopical studies. Indian J. Exp. Biol. 20:1982;559-571.
49. Sodhi A., Prasad S.B. Differential binding of conA and WGA on the cell-surface, the role of sialic-acid in their expression and the increased activity of sialidase after cis-Platin treatment. Experientia. 41:1985;93-95.
50. Rosenfeld C., Paintrand M., Choquet C., Venuat A.M. Cyclic variations in the ruthenium red stained coat of cells from a synchronized human lymphoblastoid line. Exp. Cell Res. 79:1973;465-468.
51. Eckhart W., Dulbecco R., Burger M.M. Temperature-dependent surface changes in cells infected or transformed by a thermosensitive mutant of polyoma virus. Proc. Natl. Acad. Sci. U. S. A. 68:1971;283-286.
52. Inbar M., Sachs L. Interaction of the carbohydrate-binding protein concanavalin A with normal and transformed cells. Proc. Natl. Acad. Sci. U. S. A. 63:1969;1418-1425.
53. Barth R.F., Madyastha K.R., Madyastha P.R. Agglutination of 2,4-dinitrophenyl-tagged normal human leukocytes by concanavalin A: possible relationship to their ability to evoke production of leukemia-associated antibodies. J. Natl. Cancer Inst. 54:1975;73-76.
54. Csuka O., Sugár J. Cell surface properties of L1210 leukaemia cells. Acta Morphol. Acad. Sci. Hung. 24:1976;297-305.
55. De Carlos A., Caride-Castro A., Martinez-Zorzano V.S., De La Cadena M.P., Rodriguez-Berrocal F.J. Lectin isolation and detection of N-glycoproteins bearing sialic acid and L-fucose residues in human colorectal mucosa and in adenocarcinoma biopsies. Int. J. Oncol. 20:2002;367-372.